Zhen-wei Pan
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Bclaf1 drives heart failure by recruiting Srsf2 to enhance Hand2 pre-mRNA splicing and pathological hypertrophy.
Journal: Nature communications
Published: August 04, 2025
Cullin-associated and neddylation-dissociated protein 1 (CAND1) promotes cardiomyocyte proliferation and heart regeneration by enhancing the ubiquitinated degradation of Mps one binder kinase activator 1b (Mob1b).
Journal: Cell death and differentiation
Published: December 12, 2024
Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade.
Journal: Cell metabolism
Published: December 03, 2024
eIF4A1 exacerbates myocardial ischemia-reperfusion injury in mice by promoting nuclear translocation of transgelin/p53.
Journal: Acta pharmacologica Sinica
Published: August 13, 2024
Anti-CTLA-4 m2a Antibody Exacerbates Cardiac Injury in Experimental Autoimmune Myocarditis Mice By Promoting Ccl5-Neutrophil Infiltration.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 13, 2024
Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
Journal: Acta pharmacologica Sinica
Published: January 08, 2024
Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation.
Journal: Nature communications
Published: December 05, 2023
Cullin-associated and neddylation-dissociated protein 1 (CAND1) alleviates NAFLD by reducing ubiquitinated degradation of ACAA2.
Journal: Nature communications
Published: January 07, 2023
Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarction.
Journal: Cell chemical biology
Published: November 24, 2022
GDF11 promotes wound healing in diabetic mice via stimulating HIF-1ɑ-VEGF/SDF-1ɑ-mediated endothelial progenitor cell mobilization and neovascularization.
Journal: Acta pharmacologica Sinica
Published: June 14, 2022
Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution.
Journal: Gene therapy
Published: October 22, 2021
Last Updated: 09/26/2026